Please login to the form below

Not currently logged in


This page shows the latest capivasertib news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca’s two advanced breast cancer trials meet primary endpoints

AstraZeneca’s two advanced breast cancer trials meet primary endpoints

CAPItello-291 is a phase 3, double-blind trial evaluating the efficacy of capivasertib in combination with Faslodex versus placebo plus Faslodex in patients with hormone receptor (HR)-positive human epidermal ... Susan Galbraith, executive vice president,

Latest news

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts


Add my company
Genesis Research

Genesis Research is an international HEOR and RWE research organization. A leader in evidence strategy, generation and communication, the company...

Latest intelligence

The speed of science and the pace of comms
Pharma red tape slows comms but there is a solution, Paul Hutchings, founder of fox&cat, writes....
Improving cardiovascular disease care and awareness
Scott Curley talks to PME about the risks of CVD and the importance of getting the right treatment at the right time...
Virtual Patient Engagement Program: A Customer Story
Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......